Table 4.
Mean difference of IVIG in changes in progression of sEV levels measured at baseline (S1) to sixth gestational week (S2).
| EV Markers | CI (95 %) Mean Difference (IVIG/no IVIG) of Changes (S1–S2) |
p |
|---|---|---|
| AnnexinV | −30.29; −3.33 | 0.019 |
| CD9 | −11; 0.92 | NS |
| CD63 | −14.43; −1.74 | 0.017 |
| CD81 | −16.16; −3.27 | 0.005 |
| CD4 | −9.24; 1.18 | NS |
| CD8 | −5.42; −0.27 | 0.033 |
| CD45 | −19.37; −0.67 | 0.038 |
| TRAIL | −17.53; 0.62 | NS |
| HLA DR/DP/DQ | −14.28; −1.96 | 0.014 |
| HLA G | −8.93; 2.09 | NS |
| FasL | −33.33; −3.47 | 0.021 |
| Hsp70 | −9.14; 1.07 | NS |
| CD31 | −34.78; −4.55 | 0.016 |
| CD142 | −10.4; 0.321 | 0.063 |
| PLAP | −20.02; −2.62 | 0.016 |
| CAIX | −13.62; −2.69 | 0.006 |
| CAIXII | −26.49; −1.56 | 0.031 |
NS = nonsignificant.